Article
CHOPPI: A web tool for the analysis of immunogenicity risk from host cell proteins in CHO‐based protein production
2 Jun 2014
Abstract excerpt
Despite high quality standards and continual process improvements in manufacturing, host cell protein (HCP) process impurities remain a substantial risk for biological products. Even at low levels, residual HCPs can induce a detrimental immune response compromising the safety and efficacy of a biologic. Consequently, advanced-stage clinical trials have been cancelled due to the identification of antibodies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
